AKZOY · Akzo Nobel NV
Price & Indicators
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Specialty Chemicals — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
AKZOY
this stock
Akzo Nobel NV
|
$11.26B | -5.2% | — | — | 0.0% |
|
LIN
Linde PLC
|
$232.08B | +18.1% | +3.0% | 32.5 | 1.3% |
|
AIQUF
L Air Liquide SA /Fi
|
$123.29B | +2.9% | — | — | 0.0% |
|
SHW
Sherwin Williams Co
|
$80.50B | +2.3% | +2.1% | 30.6 | 2.8% |
|
ECL
Ecolab Inc.
|
$80.16B | +8.9% | +2.2% | 38.4 | 1.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- Filed
- Oct 16, 2026
- This year
- 11
Akzo Nobel N.V. announced an Extraordinary General Meeting for November 30, 2026 to vote on proposals tied to its planned all-share merger of equals with Axalta Coating Systems Ltd., including renaming the combined company Axanzo N.V. (ticker AXZ) and appointing three non-executive directors.
ViewPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| AKZOY | +1.7% | +2.7% | +12.1% | +2.7% | -5.2% |
| SPY | -1.5% | -0.9% | +7.7% | +0.5% | +12.4% |
| vs SPY | +3.2% | +3.6% | +4.4% | +2.2% | -17.6% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.